Therefore, inhibition of DYRK1A by PPM1B may or may not also modulate these multiple factors in concert, affecting the formation of Aβ-containing senile plaques or α-synuclein-containing Lewy bodies and the progression of AD and PD. This evidence concerns the gene DYRK1A and Parkinson disease.